AOD 9604 (5mg)
The Fat-Burning Fragment — Without Growth Hormone Side Effects
Order AOD 9604 (5mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
AOD 9604 is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Targeted fat metabolism
- Blocks new fat cell formation
- No IGF-1 or growth effects
- No blood sugar impact
What is AOD 9604?
Amino acids 176-191 of hGH — the part responsible for fat burning — isolated without growth effects.
Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
AOD 9604 is a synthetic peptide fragment comprising amino acids 176-191 of human growth hormone (hGH) — the specific domain responsible for lipolytic (fat-burning) activity. It stimulates lipolysis and inhibits lipogenesis through the beta-3 adrenergic receptor pathway. Critically, it does NOT stimulate IGF-1 production, meaning it provides the fat-metabolizing benefits of GH without the growth-promoting or glucose-raising effects.
What are the research questions?
- Fat metabolism research: Specifically targets adipose tissue without affecting growth, glucose, or insulin.
- Cartilage and joint repair: Received FDA GRAS designation for food use and has been studied for osteoarthritis in Australian clinical trials.
- Metabolic syndrome: Studied for its potential role in addressing obesity-related metabolic dysfunction without the insulin resistance associated with full GH.
What does the published work describe?
Phase 2 clinical trials (Metabolic Pharmaceuticals, Australia) showed dose-dependent fat loss over 12 weeks, though the effect size was modest in obese subjects. FDA GRAS Notice GRN 000678 confirmed safety. Preclinical: significant reduction in body fat in obese Zucker rats without changes in IGF-1 or insulin.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Heffernan MA et al. Endocrinology 2000
- FDA GRAS Notice GRN 000678
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is AOD 9604 handled in the lab?
For AOD 9604, record the product code AOD-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for AOD 9604 from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For AOD 9604, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 1815.08 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied AOD 9604 form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A AOD 9604 laboratory protocol should record identity, product code AOD-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- AOD 9604
- CAS Number
- 221231-10-3
- Molecular Weight
- 1815.08 g/mol
- HPLC Purity Specification
- ≥98%
- Category
- GLP-1 & Metabolic
- Starting Price
- $49.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
AOD 9604 has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is AOD 9604?
AOD 9604 is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of AOD 9604 are available?
The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret AOD 9604 purity results?
AOD 9604 has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should AOD 9604 be handled in the laboratory?
For AOD 9604, record the product code AOD-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for AOD 9604?
Choose a solvent for AOD 9604 from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a AOD 9604 stock concentration?
For AOD 9604, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 1815.08 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should AOD 9604 be stored after preparation?
Use the documented storage conditions for the supplied AOD 9604 form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a AOD 9604 lab protocol document?
A AOD 9604 laboratory protocol should record identity, product code AOD-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this AOD 9604 product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this AOD 9604 lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is AOD 9604 for human use?
No. AOD 9604 is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
